Catalyst Wire Dossier Catalyst Wire Dossier

CD62L Depleted Donor Lymphocyte Infusion

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD62L Depleted Donor Lymphocyte Infusion, covering 2025-09-15 to 2025-09-15. Get the full timeline:

Most recent: Clinical Trial Update: CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation [Phase 2]

See pricing